Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04245839
Title A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL) (TRANSCEND FL)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Celgene
Indications

marginal zone B-cell lymphoma

follicular lymphoma

Therapies

Lisocabtagene maraleucel

Cyclophosphamide + Fludarabine

Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.